研究单位：[1]Sun Yat-sen University[2]BeiGene[3],Foshan,Guangdong,China,528000[4],Dusit,Bangkok,Thailand,10300[5],Ratchathewi,Bangkok,Thailand,10400[6],Song Phi Nong,Hat Yai,Thailand,90110[7],Chiang Mai,Muang,Thailand,50200[8],Khon Kaen,Muang,Thailand,40002[9]Anhui Provincial Cancer Hospital,Hefei,Anhui,China,230088[10]Beijing Cancer Hospital,Beijing,Beijing,China,100142[11]Cancer Hospital Chinese Academy of Medical Science,Beijing,Beijing,China[12]Chongqing Three Gorges Central Hospital,Chongqing,Chongqing,China,404199[13]Fujian Provincial Cancer Hospital,Fuzhou,Fujian,China,350014[14]First Affiliated Hospital of Xiamen University,Xiamen,Fujian,China,361003[15]The first Affiliated Hospital of guangzhou University of traditional chinese medicine - Oncology,Guangzhou,Guangdong,China,510000[16]Cancer Center of Guangzhou Medical University,Guangzhou,Guangdong,China,510059[17]Guangdong Provincial People's Hospital,Guangzhou,Guangdong,China,510080[18]Sun Yat-sen Memorial Hospital , Sun Yat-sen University,Guangzhou,Guangdong,China[19]Cancer Hospital of Shantou University Medical College - Oncology,Shantou,Guangdong,China,515031[20]Affiliated Hospital of Guangdong Medical University,Zhanjiang,Guangdong,China,524000[21]People''s Hospital of Zhongshan City,Zhongshan,Guangdong,China,528400[22]Guangxi Medical University Affiliated Tumor Hospital& Oncology Medical College,Nanning,Guangxi,China,530021[23]Hainan General Hospital - Oncology,Haikou,Hainan,China[24]Harbin Medical University Cancer Hospital - Oncology,Haerbin,Heilongjiang,China,150081[25]Hubei Cancer Hospital - Oncology,Wuhan,Hubei,China,400037[26]Union Hospital of Tongji Medical College, Huazhong University of Science and Technology,Wuhan,Hubei,China[27]Hunan Cancer Hospital,Changsha,Hunan,China,410006[28]Changsha Central Hospital,Changsha,Hunan,China,410018[29]Affiliated hospital of Nantong university,Nantong,Jiangsu,China,226001[30]The First affiliated hospital of Nanchang University,Nanchang,Jiangxi,China,330006[31]Affiliated Zhongshan Hospital of Fudan University,Shanghai,Shanghai,China,200032[32]Fudan University Shanghai Cancer Center,Shanghai,Shanghai,China,200120[33]Shanghai East Hospital,Shanghai,Shanghai,China,200120[34]West China Hospital ,Sichuan University,Chengdu,Sichuan,China,610041[35]Sichuan Cancer Hospital,Chengdu,Sichuan,China,610042[36]Yunnan Province Cancer Hospital,Kunming,Yunnan,China[37]Zhejiang Cancer Hospital,Hangzhou,Zhejiang,China,310022[38]Changhua Christian Hospital,Changhua,NAP,Taiwan,500-06[39]Chang Gung Memorial Hospital, Kaohsiung,Kaohsiung,Taiwan,833[40]Taichung Veterans General Hospital,Taichung,Taiwan[41]National Cheng Kung University Hospital,Tainan,Taiwan,704[42]National Taiwan University Hospital,Taipei,Taiwan,100[43]Taipei Veterans General Hospital,Taipei,Taiwan,112[44]Chang Gung Memorial Hospital, Linkou,Taoyuan,Taiwan,33305
研究目的：
This is a Phase 3, Multicenter, Double-Blind, Randomized, Placebo-controlled Study to Compare the Efficacy and Safety of Tislelizumab (BGB-A317) Combined With Gemcitabine Plus Cisplatin Versus Placebo Combined With Gemcitabine Plus Cisplatin as First Line Treatment for Recurrent or Metastatic Nasopharyngeal Cancer.
